Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

boehringer ingelheim vetmedica gmbh - mycoplasma hyopneumoniae, inactivado, cepa j, b-3745 - suspensiÓn inyectable - mycoplasma hyopneumoniae, inactivado, cepa j, b-3745 1,0 - mycoplasma - cerdos de engorde; cerdos de reposición

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

merck sharp & dohme animal health s.l. - mycoplasma hyopneumoniae (cepa attc nº 25934) - emulsiÓn inyectable - mycoplasma hyopneumoniae (cepa attc nº 25934) minimo 1,47 - mycoplasma - cerdos de engorde

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

merck sharp & dohme animal health s.l. - mycoplasma gallisepticum (cepa 6/85) - liofilizado para suspension oculonasal - mycoplasma gallisepticum (cepa 6/85) 7943282.34 - mycoplasma - gallina-pollitas futuras ponedoras

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

merck sharp & dohme animal health s.l. - mycoplasma hyopneumoniae (11) - emulsiÓn inyectable - mycoplasma hyopneumoniae (11) 6,5 log2 - mycoplasma - porcino

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

zoetis spain s.l. - mycoplasma hyopneumoniae, inactivado, cepa p-5722-3 - suspensiÓn inyectable - mycoplasma hyopneumoniae, inactivado, cepa p-5722-3 1 - mycoplasma - lechones

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

zoetis spain s.l. - mycoplasma hyopneumoniae, inactivado, cepa p-5722-3 - emulsiÓn inyectable - mycoplasma hyopneumoniae, inactivado, cepa p-5722-3 ≤1 - mycoplasma - cerdos de engorde

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

vetia animal health s.a.u. - mycoplasma hyopneumoniae, inactivado, cepa 1137/99 - emulsiÓn inyectable - mycoplasma hyopneumoniae, inactivado, cepa 1137/99 1 - mycoplasma - lechones

Den europeiske union - spansk - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - cerdos - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

zoetis spain s.l. - mycoplasma bovis vivo atenuado, cepa n2805-1 - liofilizado y disolvente para suspensiÓn inyectable - mycoplasma bovis vivo atenuado, cepa n2805-1 0,22 x 107 - mycoplasma - bovino

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glaxosmithkline s.a. - salmeterol xinafoato; fluticasona propionato - suspensiÓn para inhalaciÓn en envase a presiÓn - 25 microgramos/125 microgramos/dosis - salmeterol xinafoato 25 microgramos; fluticasona propionato 125 microgramos - salmeterol y fluticasona